Apr 9 |
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Pa...
|
Mar 29 |
Molecular Templates GAAP EPS of -$0.73, revenue of $7.02M
|
Mar 29 |
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
|
Mar 28 |
Molecular Templates announces $9.5M private placement offering
|
Mar 28 |
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
|
Mar 19 |
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
|
Feb 8 |
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Nov 1 |
Molecular Templates to Participate in Upcoming Investor Conferences
|